Johnson & Johnson news

   Watch this stock
Showing stories 11 - 20 of about 122   

Articles published

JNJ 103.10 -0.39 (-0.38%)
price chart
Ex-Dividend Reminder: Johnson & Johnson, Steris and McGraw Hill Financial
Looking at the universe of stocks we cover at Dividend Channel, on 8/22/14, Johnson & Johnson (NYSE: JNJ), Steris Corp.
Related articles »  
Johnson & Johnson Can Only Get Better When It Gets Cheaper
With its stellar line of products and an industry-leading operating margin of 28% there are few if any fundamental reasons why Johnson & Johnson will correct for long. Yet, when I consider the five-year average annual dividend yield for JNJ is 3.30%, ...
Johnson & Johnson: A Quality Dividend Company At Attractive Valuation (JNJ)  Seeking Alpha (registration)
Related articles »  
Johnson & Johnson app makes it a snap to help students with United Way
6, 2014 /PRNewswire-USNewswire/ -- Johnson & Johnson, with an exclusive partnership at Walmart, just launched a new back to school campaign with United Way to support students through mentoring and tutoring, in order to ultimately improve their school ...
Sell Side Views On Johnson & Johnson
Citi has raised its 12-month target price for Johnson & Johnson (JNJ) to $122.2, from $117. The reason for upgrading the target price is JNJ's strong second quarter results, the growth prospects of its HepC drug (Olysio), and an increase in R&D ...
Why Johnson & Johnson (JNJ) Stock Is Lower Today
NEW YORK (TheStreet) -- Shares of Johnson & Johnson (JNJ_) are down -0.66% to $101.62 in pre-market trade after the health care products company last night said it was withdrawing a surgical tool that can spread cancer in women, effectively removing ...
5 Things Johnson & Johnson's Management Wants You to Know
A month ago today healthcare giant Johnson & Johnson (NYSE: JNJ ) reported what looked on the surface to be another stellar quarter of growth.
Robert Wood Johnson's New Industry Made Surgery Safer  Investor's Business Daily
Related articles »  
Is This A Good Time To Invest In Johnson & Johnson?
Johnson & Johnson (J&J) (JNJ) stock fell 6% earlier this month, following the news of the company's recall of its laparoscopic power morcellators.
Johnson & Johnson Pulls The Plug On Power Morcellators
Johnson & Johnson (JNJ) withdrew power morcellators from the market last week following a warning by US regulators that the surgical tool may spread cancer in women.
Johnson & Johnson Recalls Laparoscopic Surgery Power Morcellators  Legal Examiner
Johnson & Johnson Asks Customers to Return Morcellators  OutpatientSurgery.net
Related articles »  
Johnson & Johnson seeks to dismiss class-action talcum powder suit
On May 23, Mihalich filed suit in Illinois' Southern District Court, seeking class-action status on behalf of herself and other women in the state who had bought Johnson's Baby Powder, on the grounds that ´┐Żeveryone who bought Baby Powder should get ...
Johnson & Johnson: Becoming More Attractive Each Day
Johnson & Johnson (NYSE:JNJ), which is one of my favorite long-term stocks for income and dividend-reinvesting investors, just dropped below the $100.00-per-share level and is becoming more attractive each day.
Related articles »